Canada markets closed

Soleno Therapeutics, Inc. (6XC.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
37.48-0.90 (-2.34%)
At close: 03:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.42B
Enterprise Value 1.28B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)10.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.02

Trading Information

Stock Price History

Beta (5Y Monthly) -1.40
52-Week Change 3837.00%
S&P500 52-Week Change 326.24%
52 Week High 348.40
52 Week Low 33.43
50-Day Moving Average 336.64
200-Day Moving Average 331.48

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 536.86M
Implied Shares Outstanding 637.8M
Float 815.79M
% Held by Insiders 11.53%
% Held by Institutions 1101.32%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 26, 2022

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.55%
Return on Equity (ttm)-71.26%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -51.62M
Net Income Avi to Common (ttm)-52.03M
Diluted EPS (ttm)-1.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)149.63M
Total Cash Per Share (mrq)4.49
Total Debt (mrq)347k
Total Debt/Equity (mrq)0.24%
Current Ratio (mrq)11.23
Book Value Per Share (mrq)4.30

Cash Flow Statement

Operating Cash Flow (ttm)-30.74M
Levered Free Cash Flow (ttm)-14.69M